USRE46190EActiveUtility
High-molecular weight conjugate of steroids
Est. expirySep 28, 2027(~1.2 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 37/02A61P 37/08A61K 47/645A61K 31/785A61P 35/00A61P 29/00A61K 47/60A61P 31/00A61K 47/48315A61K 47/48215
60
PatentIndex Score
0
Cited by
449
References
10
Claims
Abstract
Enzymes in the body vary among different species, and also vary among individuals of the same species. Thus, it has been demanded to develop a novel steroid-containing pharmaceutical preparation which can release a drug in a manner independent of the enzymes present in the body, and which is expected to have an efficacious therapeutic effect. Disclosed is a high-molecular weight conjugate of a steroid, comprising a structure in which a carboxylic acid group of a polymer having a polyethylene glycol moiety and a succinic acid monoamide moiety having two or more succinic acid monoamide units is ester-bonded to a hydroxy group in the steroid.
Claims
exact text as granted — not AI-modifiedThe invention claimed is:
1. A high-molecular weight conjugate of steroids, comprising a structure in which a carboxylic acid group of a block copolymer having a polyethylene glycol moiety and polyaspartic acid is ester-bonded to an alcoholic hydroxy group in the steroids, and
wherein the conjugate is represented by formula (I)
wherein R1 represents a (C1-C6) alkyl group; R2 represents a (C2-C6) alkylene group; R3 represents a (C1-C6) acyl group; R4 —OR4 represents an alcoholic hydroxy group of said steroids; R5 represents a group selected from the group consisting of a (C1-C30) alkoxy group, a (C7-C30) aralkyloxy group, a (C1-C30) alkylamino group, a di(C1-C30) alkylamino group, an amino acid with a protected carboxy group and —N(R6)CONH(R7) wherein R6 and R7, which may be identical or different from each other, represent a (C3-C6) cyclic alkyl group or a (C1-C5) alkyl group which may be substituted with a tertiary amine group; t represents an integer from 100 to 300; and d, e, f, g, h, i or j each independently represents an integer from 0 to 100; provided that d+e represents an integer from 1 to 100, d+e+f+g+h+i+j represents an integer from 6 to 100; and respective units of the polyaspartic acid are bonded in any order.
2. The high-molecular weight conjugate of steroids according to claim 1 , wherein R1 represents a (C1-C3) alkyl group, R2 represents a (C2-C4) alkylene group, R3 represents a (C1-C3) acyl group, t represents an integer from 100 to 300, and d, e, f, g, h, i or j each independently represents an integer from 0 to 90, provided that d+e represents an integer from 1 to 90 and d+e+f+g+h+i+j represents an integer from 15 to 90.
3. The high-molecular weight conjugate of steroids according to claim 1 or 2 , in which the steroids are prednisolone, methyl prednisolone, dexamethasone, betamethasone, clobetasol, diflorasone, diflucortolone, fluocinolone acetonide, hydrocortisone, difluprednate, beclometasone, triamcinolone or alclometasone.
4. A method of manufacturing the high-molecular weight conjugate of steroids described in claim 1 , the method comprising ester-bonding a carboxylic acid group of a block copolymer having a polyethylene glycol moiety and polyaspartic acid to an alcoholic hydroxy group of the steroids, by using a dehydrating condensation agent in an organic solvent.
5. A pharmaceutical composition comprising as an active ingredient the high-molecular weight conjugate of steroids according to claim 1 .
6. An anti-inflammatory agent comprising as an active ingredient the high-molecular weight conjugate of steroids according to claim 1 .
7. An anti-rheumatism agent comprising as an active ingredient the high-molecular weight conjugate of steroids according to claim 1 .
8. An agent for treating collagen disease comprising as an active ingredient the high-molecular weight conjugate of steroids according to claim 1 .
9. An anti-allergy agent comprising as an active ingredient the high-molecular weight conjugate of steroids according to claim 1 .
10. The high-molecular weight conjugate of steroids according to claim 2, in which the steroids are prednisolone, methyl prednisolone, dexamethasone, betamethasone, clobetasol, diflorasone, diflucortolone, fluocinolone acetonide, hydrocortisone, difluprednate, beclometasone, triamcinolone or alclometasone.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.